Annals of Emergency Medicine
Volume 45, Issue 4 , Pages 363-376, April 2005

2004 American College of Cardiology/American Heart Association Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: Implications for Emergency Department Practice

From the Pennsylvania Hospital, University of Pennsylvania Health System, Philadelphia, PA (Pollack); University of California at Davis, Sacramento, CA (Diercks); and Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (Roe, Peterson)

Received 2 September 2004; received in revised form 15 October 2004; accepted 1 November 2004. published online 15 February 2005.

The American College of Cardiology and the American Heart Association last published evidence-based guidelines for the management of ST-segment elevation myocardial infarction (STEMI) in 1999. In mid-2004, in recognition of the evolution and improvement of many of the most basic tenets of clinical management of STEMI since that time, an updated edition of the STEMI guidelines has been published. These guidelines offer many evidence-based recommendations that are pertinent to the out-of-hospital and emergency department care of STEMI patients, including initial evaluation, risk stratification, stabilizing management, and the choice between pharmacologic and mechanical revascularization. These are presented and discussed here.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Funding and support: All authors have received honoraria or research support (direct or indirect) from Aventis Pharmaceuticals, Millennium Pharmaceuticals, Schering-Plough, Bristol-Myers-Squibb, and Sanofi, which market therapeutic agents cited in this article. Dr. Pollack has received honoraria from Genentech.Reprints not available from the authors.

PII: S0196-0644(04)01617-8

doi:10.1016/j.annemergmed.2004.11.003

Annals of Emergency Medicine
Volume 45, Issue 4 , Pages 363-376, April 2005

Article Tools

* Image Usage & Resolution